579 related articles for article (PubMed ID: 24140630)
1. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).
White HD; Tonkin A; Simes J; Stewart R; Mann K; Thompson P; Colquhoun D; West M; Nestel P; Sullivan D; Keech AC; Hunt D; Blankenberg S;
J Am Coll Cardiol; 2014 Feb; 63(4):345-54. PubMed ID: 24140630
[TBL] [Abstract][Full Text] [Related]
2. Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study.
Funke-Kaiser A; Mann K; Colquhoun D; Zeller T; Hunt D; Simes J; Sullivan D; Sydow K; West M; White H; Blankenberg S; Tonkin AM;
Int J Cardiol; 2014 Mar; 172(2):411-8. PubMed ID: 24508492
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.
Nestel PJ; Barnes EH; Tonkin AM; Simes J; Fournier M; White HD; Colquhoun DM; Blankenberg S; Sullivan DR
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2902-8. PubMed ID: 24092750
[TBL] [Abstract][Full Text] [Related]
4. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.
LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease)
Lancet; 2002 Apr; 359(9315):1379-87. PubMed ID: 11978335
[TBL] [Abstract][Full Text] [Related]
5. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
Hague W; Forder P; Simes J; Hunt D; Tonkin A;
Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
[TBL] [Abstract][Full Text] [Related]
6. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
West MJ; Nestel PJ; Kirby AC; Schnabel R; Sullivan D; Simes RJ; Pollicino C; Lubos E; Münzel TF; White HD; Tonkin AM; Bickel C; Tiret L; Blankenberg S;
Eur Heart J; 2008 Apr; 29(7):923-31. PubMed ID: 18296678
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study.
Tonkin AM; Blankenberg S; Kirby A; Zeller T; Colquhoun DM; Funke-Kaiser A; Hague W; Hunt D; Keech AC; Nestel P; Stewart R; Sullivan DR; Thompson PL; West M; White HD; Simes J;
Int J Cardiol; 2015 Dec; 201():499-507. PubMed ID: 26318511
[TBL] [Abstract][Full Text] [Related]
8. D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study.
Simes J; Robledo KP; White HD; Espinoza D; Stewart RA; Sullivan DR; Zeller T; Hague W; Nestel PJ; Glasziou PP; Keech AC; Elliott J; Blankenberg S; Tonkin AM;
Circulation; 2018 Aug; 138(7):712-723. PubMed ID: 29367425
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.
Omland T; Pfeffer MA; Solomon SD; de Lemos JA; Røsjø H; Šaltytė Benth J; Maggioni A; Domanski MJ; Rouleau JL; Sabatine MS; Braunwald E;
J Am Coll Cardiol; 2013 Mar; 61(12):1240-9. PubMed ID: 23414791
[TBL] [Abstract][Full Text] [Related]
10. Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
Simes RJ; Marschner IC; Hunt D; Colquhoun D; Sullivan D; Stewart RA; Hague W; Keech A; Thompson P; White H; Shaw J; Tonkin A;
Circulation; 2002 Mar; 105(10):1162-9. PubMed ID: 11889008
[TBL] [Abstract][Full Text] [Related]
11. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.
Jia X; Sun W; Hoogeveen RC; Nambi V; Matsushita K; Folsom AR; Heiss G; Couper DJ; Solomon SD; Boerwinkle E; Shah A; Selvin E; de Lemos JA; Ballantyne CM
Circulation; 2019 Jun; 139(23):2642-2653. PubMed ID: 31030544
[TBL] [Abstract][Full Text] [Related]
12. Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study.
Söderberg S; Colquhoun D; Keech A; Yallop J; Barnes EH; Pollicino C; Simes J; Tonkin AM; Nestel P;
Int J Obes (Lond); 2009 Jan; 33(1):123-30. PubMed ID: 19050671
[TBL] [Abstract][Full Text] [Related]
13. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
Lindahl B; Toss H; Siegbahn A; Venge P; Wallentin L
N Engl J Med; 2000 Oct; 343(16):1139-47. PubMed ID: 11036119
[TBL] [Abstract][Full Text] [Related]
14. Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies.
Januzzi JL; Newby LK; Murphy SA; Pieper K; Antman EM; Morrow DA; Sabatine MS; Ohman EM; Cannon CP; Braunwald E
Am Heart J; 2006 Feb; 151(2):360-6. PubMed ID: 16442899
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.
Ivanes F; Susen S; Mouquet F; Pigny P; Cuilleret F; Sautière K; Collet JP; Beygui F; Hennache B; Ennezat PV; Juthier F; Richard F; Dallongeville J; Hillaert MA; Doevendans PA; Jude B; Bertrand M; Montalescot G; Van Belle E
Eur Heart J; 2012 Jan; 33(2):191-202. PubMed ID: 21719456
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of low-level cardiac troponin-I elevations in patients without definite acute coronary syndromes.
Pham MX; Whooley MA; Evans GT; Liu C; Emadi H; Tong W; Murphy MC; Fleischmann KE
Am Heart J; 2004 Nov; 148(5):776-82. PubMed ID: 15523306
[TBL] [Abstract][Full Text] [Related]
17. White blood cell count predicts reduction in coronary heart disease mortality with pravastatin.
Stewart RA; White HD; Kirby AC; Heritier SR; Simes RJ; Nestel PJ; West MJ; Colquhoun DM; Tonkin AM;
Circulation; 2005 Apr; 111(14):1756-62. PubMed ID: 15809366
[TBL] [Abstract][Full Text] [Related]
18. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.
Giraldez RR; Giugliano RP; Mohanavelu S; Murphy SA; McCabe CH; Cannon CP; Braunwald E
J Am Coll Cardiol; 2008 Sep; 52(11):914-20. PubMed ID: 18772061
[TBL] [Abstract][Full Text] [Related]
19. Circulating high-mobility group box 1 and cardiovascular mortality in unstable angina and non-ST-segment elevation myocardial infarction.
Hashimoto T; Ishii J; Kitagawa F; Yamada S; Hattori K; Okumura M; Naruse H; Motoyama S; Matsui S; Tanaka I; Izawa H; Maruyama I; Nomura M; Ozaki Y
Atherosclerosis; 2012 Apr; 221(2):490-5. PubMed ID: 22369934
[TBL] [Abstract][Full Text] [Related]
20. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
